StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Educatedopinionon Nov 18, 2020 12:05pm

131 Views

Post# 31922654

RE:RE:RE:RE:RE:RE:RE:Last Chance

Vaccine or no vaccine the testing market is here for at least a year,it has been a godsend to the company but as i had said in a previous post, while testing provides short term cash flow , it is not viable as a long term business model , it might evolve somewhat but we don't have a crystal ball as to what the future holds .
Irrelevant of the 3rd q results , i think the company is way undervalued based on their IP and we will see substantially higher SP within the next 6 months to a year , revenue from covid testing might even give it more hype.

Bullboard Posts

How one company is disrupting PoC testing